POLY(2-ETHYLHEXYL ACRYLATE-CO-METHACRYLIC ACID-CO-METHYL METHACRYLATE-CO-STYRENE)
General Information
Mainterm | POLY(2-ETHYLHEXYL ACRYLATE-CO-METHACRYLIC ACID-CO-METHYL METHACRYLATE-CO-STYRENE) |
CAS Reg.No.(or other ID) | 28377-44-8 |
Regnum |
175.105 175.320 176.170 176.180 177.1010 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 168791 |
IUPAC Name | 4-ethyl-2-methylideneoctanoic acid;methyl 2-methylprop-2-enoate;2-methylprop-2-enoic acid;styrene |
InChI | InChI=1S/C11H20O2.C8H8.C5H8O2.C4H6O2/c1-4-6-7-10(5-2)8-9(3)11(12)13;1-2-8-6-4-3-5-7-8;1-4(2)5(6)7-3;1-3(2)4(5)6/h10H,3-8H2,1-2H3,(H,12,13);2-7H,1H2;1H2,2-3H3;1H2,2H3,(H,5,6) |
InChI Key | LJVBKZJGPMGLHH-UHFFFAOYSA-N |
Canonical SMILES | CCCCC(CC)CC(=C)C(=O)O.CC(=C)C(=O)O.CC(=C)C(=O)OC.C=CC1=CC=CC=C1 |
Molecular Formula | C28H42O6 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 474.638 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Complexity | 419.0 |
CACTVS Substructure Key Fingerprint | A A A D c f B 4 O A A A A A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A B A A A A G g A A C A A A D Q C A m A I y C I A A B g C I A i D S C A A C A A A g A A A I i A E A A M g I J D K A M R C A Y A A k g A A I u I e I y K C O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 101.0 |
Monoisotopic Mass | 474.298 |
Exact Mass | 474.298 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 34 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 4 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.5676 |
Human Intestinal Absorption | HIA+ | 0.8668 |
Caco-2 Permeability | Caco2+ | 0.6012 |
P-glycoprotein Substrate | Substrate | 0.6703 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7542 |
Inhibitor | 0.8163 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8843 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7400 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8935 |
CYP450 2D6 Substrate | Non-substrate | 0.8867 |
CYP450 3A4 Substrate | Non-substrate | 0.5244 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8151 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7383 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8813 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7453 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.5934 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8133 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8934 |
Non-inhibitor | 0.8462 | |
AMES Toxicity | Non AMES toxic | 0.8393 |
Carcinogens | Non-carcinogens | 0.8354 |
Fish Toxicity | High FHMT | 0.9989 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9999 |
Honey Bee Toxicity | High HBT | 0.7404 |
Biodegradation | Ready biodegradable | 0.7073 |
Acute Oral Toxicity | III | 0.6733 |
Carcinogenicity (Three-class) | Non-required | 0.6896 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.8186 | LogS |
Caco-2 Permeability | 0.8932 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.9747 | LD50, mol/kg |
Fish Toxicity | 0.5493 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 2.1069 | pIGC50, ug/L |
From admetSAR